Tamsulosin Hydrochloride
Product Images NDC 67296-1913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67296-1913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label Tamsulosin 5026874015)

Label (Label Tamsulosin 5026874015)
This appears to be a product label for Tamsulosin Hydrochloride capsules. The label indicates that the product is in a pack size of 50 (5x10) unit dose capsules. The information includes the name of the medication, Tamsulosin Hydrochloride, as well as the strength and formulation.*
FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

Tamsu-fi2a (Tamsulosin Figure2a)
Mean Change in treatment effects measured in different groups over a specified period. The treatments include OOO 08mg, A A-pOimg, and Placebo. The study involved a total of 63 participants for one group and 65 participants for another group, with the duration of treatment measured in weeks.*
FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

Tamsu-fig2b (Tamsulosin Figure2b)
The text provides information about "Mean Change" in a treatment study, with data related to different groups and the duration of treatment in weeks. The text also mentions the number of participants in each group. The study seems to focus on evaluating the impact or effectiveness of the treatment over time.*
FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

Tamsu-fig3b (Tamsulosin Figure3b)
This text appears to be a chart or table related to treatment duration involving a percentage of 5%. It may be discussing a specific treatment plan or therapy that is typically conducted over several weeks.*
FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.